Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Acute lymphoblastic leukemia--on the wings of IKAROS.

Georgopoulos K.

N Engl J Med. 2009 Jan 29;360(5):524-6. doi: 10.1056/NEJMe0809819. No abstract available.

PMID:
19131438
2.

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Medeiros BC.

N Engl J Med. 2009 Apr 23;360(17):1787; author reply 1787-8. doi: 10.1056/NEJMc090454. No abstract available.

3.

BCR-ABL1 induces aberrant splicing of IKAROS and lineage infidelity in pre-B lymphoblastic leukemia cells.

Klein F, Feldhahn N, Herzog S, Sprangers M, Mooster JL, Jumaa H, Müschen M.

Oncogene. 2006 Feb 16;25(7):1118-24.

PMID:
16205638
4.

Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.

Mullighan CG, Su X, Zhang J, Radtke I, Phillips LA, Miller CB, Ma J, Liu W, Cheng C, Schulman BA, Harvey RC, Chen IM, Clifford RJ, Carroll WL, Reaman G, Bowman WP, Devidas M, Gerhard DS, Yang W, Relling MV, Shurtleff SA, Campana D, Borowitz MJ, Pui CH, Smith M, Hunger SP, Willman CL, Downing JR; Children's Oncology Group..

N Engl J Med. 2009 Jan 29;360(5):470-80. doi: 10.1056/NEJMoa0808253.

5.

Prognostic significance of IKZF1 alteration status in pediatric B-lineage acute lymphoblastic leukemia: a meta-analysis.

Feng J, Tang Y.

Leuk Lymphoma. 2013 Apr;54(4):889-91. doi: 10.3109/10428194.2012.723212. No abstract available.

PMID:
22916957
6.

Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations.

Dupuis A, Gaub MP, Legrain M, Drenou B, Mauvieux L, Lutz P, Herbrecht R, Chan S, Kastner P.

Leukemia. 2013 Feb;27(2):503-7. doi: 10.1038/leu.2012.204. No abstract available.

PMID:
22868967
7.
9.

Impact of IKZF1 deletions and PAX5 amplifications in pediatric B-cell precursor ALL treated according to NOPHO protocols.

Ofverholm I, Tran AN, Heyman M, Zachariadis V, Nordenskjöld M, Nordgren A, Barbany G.

Leukemia. 2013 Sep;27(9):1936-9. doi: 10.1038/leu.2013.92. No abstract available.

PMID:
23538749
10.

Analysis of Ikaros family splicing variants in human hematopoietic lineages.

Matulić M, Paradzik M, Puskarić BJ, Stipić J, Antica M.

Coll Antropol. 2010 Mar;34(1):59-62.

PMID:
20432734
11.

Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.

Takanashi M, Morimoto A, Yagi T, Kuriyama K, Kano G, Imamura T, Hibi S, Todo S, Imashuku S.

Haematologica. 2003 Nov;88(11):1238-44.

12.

Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.

Tonnelle C, Dijon M, Moreau T, Garulli C, Bardin F, Chabannon C.

Mol Immunol. 2009 May;46(8-9):1736-43. doi: 10.1016/j.molimm.2009.02.004.

PMID:
19285729
13.

Regulatory phosphorylation of Ikaros by Bruton's tyrosine kinase.

Ma H, Qazi S, Ozer Z, Zhang J, Ishkhanian R, Uckun FM.

PLoS One. 2013 Aug 19;8(8):e71302. doi: 10.1371/journal.pone.0071302.

14.

Regulation of L-selectin expression by a dominant negative Ikaros protein.

Christopherson I, Piechoki M, Liu G, Ratner S, Galy A.

J Leukoc Biol. 2001 Apr;69(4):675-83.

PMID:
11310856
15.

Linking the hematopoietic microenvironment to imatinib-resistant Ph+ B-ALL.

Dorshkind K, Witte ON.

Genes Dev. 2007 Sep 15;21(18):2249-52. No abstract available.

16.
17.

The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.

Batova A, Shao LE, Diccianni MB, Yu AL, Tanaka T, Rephaeli A, Nudelman A, Yu J.

Blood. 2002 Nov 1;100(9):3319-24.

18.

Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia.

Yang JJ, Bhojwani D, Yang W, Cai X, Stocco G, Crews K, Wang J, Morrison D, Devidas M, Hunger SP, Willman CL, Raetz EA, Pui CH, Evans WE, Relling MV, Carroll WL.

Blood. 2008 Nov 15;112(10):4178-83. doi: 10.1182/blood-2008-06-165027.

19.
20.

Identification of different Ikaros cDNA transcripts in Philadelphia-positive adult acute lymphoblastic leukemia by a high-throughput capillary electrophoresis sizing method.

Iacobucci I, Lonetti A, Cilloni D, Messa F, Ferrari A, Zuntini R, Ferrari S, Ottaviani E, Arruga F, Paolini S, Papayannidis C, Piccaluga PP, Soverini S, Saglio G, Pane F, Baruzzi A, Vignetti M, Berton G, Vitale A, Chiaretti S, Müschen M, Foà R, Baccarani M, Martinelli G.

Haematologica. 2008 Dec;93(12):1814-21. doi: 10.3324/haematol.13260. Erratum in: Haematologica. 2010 Jun;95(6):1033.

Items per page

Supplemental Content

Support Center